
Please try another search
By Manojna Maddipatla
(Reuters) -U.S. health insurer Anthem Inc on Wednesday issued a conservative annual profit forecast and warned that the highly contagious Omicron variant was likely to drive up treatment, vaccination and testing costs in the first quarter.
Since the start of the pandemic, profits of health insurers have come under pressure as huge costs related to direct COVID-19 treatment and tests cancel out any advantage gained from lower expenses due to delays in elective procedures.
"We anticipate another year in which the overall cost of care will track above normalized levels driven by COVID-related treatment, vaccination and testing costs," Chief Financial Officer John Gallina said.
Anthem shares fell about 1.3% in early morning trading after the insurer forecast 2022 adjusted profit of at least $28.25 per share, below market expectation of $28.65, according to Refinitiv data and in line with its preliminary guidance.
The company's comments on medical costs combined with a largely in-line fourth quarter are weighing on Anthem's stock, Credit Suisse (SIX:CSGN) analyst A.J. Rice said.
"I don't see anything that really changes our perspective on the stock. Anthem is one of the preferred names in managed care right now. This (stock move) will be short lived."
In contrast, rival UnitedHealth Group (NYSE:UNH) had last week predicted softer blow this year from the pandemic on expectation that added costs related to the Omicron surge would be offset by delays in non-urgent healthcare procedures.
Anthem said it expects annual benefit expense ratio - the percentage of premiums paid for medical services - to be between 87.5% and 88.5%. The midpoint is above analysts' estimate of 87.50%.
The lower the ratio, the better it is for a health insurer as it indicates a tight rein on costs. For Anthem, it was 87.5% in 2021, mainly due to rise in costs related to COVID-related care.
By Sabrina Valle HOUSTON (Reuters) - More than 200 people gathered in front of a federal courthouse in Houston, Texas on Friday, to voice their anger after the Supreme Court...
BERLIN (Reuters) - German sugar producer Suedzucker plans "significant" price hikes to offset rising costs and prepares to shift to coal as Russian gas supplies to Western Europe...
BERLIN (Reuters) - Lufthansa does not expect its global airline operations to return to normal until 2023 after staff shortages and booming demand amid the lifting of COVID-19...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.